Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro

By Alves A.C.   Pires A.L.A.   Cruz H.N.   Serra M.F.   Diaz B.L.   Cordeiro R.S.B.   Lagente V.   Martins M.A.   e Silva P.M.R.  

European Journal of Pharmacology, Vol. 312, Iss. 1, 1996-09 ,pp. : 89-96

Elsevier

Access to resources Recommend Favorite

Levosimendan increases L-type Ca 2+ current via phosphodiesterase-3 inhibition in human cardiac myocytes

By Ajiro Y.   Hagiwara N.   Katsube Y.   Sperelakis N.   Kasanuki H.  

European Journal of Pharmacology, Vol. 435, Iss. 1, 2002-01 ,pp. : 27-33

Elsevier

Access to resources Recommend Favorite

Phosphodiesterase type 5 inhibition ameliorates nephrotoxicity induced by cyclosporin A in spontaneous hypertensive rats

By Hosogai N.   Tomita M.   Hamada K.   Ogawa T.   Hirosumi J.   Manda T.   Mutoh S.  

European Journal of Pharmacology, Vol. 477, Iss. 2, 2003-09 ,pp. : 171-178

Elsevier

Access to resources Recommend Favorite

Myocardial contractility after infarction and carnitine palmitoyltransferase I inhibition in rats

By Gunther J.   Wagner K.-D.   Theres H.   Schimke I.   Born A.   Scholz H.   Vetter R.  

European Journal of Pharmacology, Vol. 406, Iss. 1, 2000-10 ,pp. : 123-126

Elsevier

Access to resources Recommend Favorite

Selective phosphodiesterase type 5 inhibition using tadalafil for the treatment of erectile dysfunction

By Kuan James   Brock Gerald  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 11, 2002-11 ,pp. : 1605-1613

Informa Healthcare

Access to resources Recommend Favorite